Shared genetic basis for brain structure, insulin resistance and inflammation in schizophrenia: a colocalization study

Schizophrenia (SZ) is accompanied by structural brain alterations and elevated cardiometabolic risk, potentially linked through shared immune–metabolic mechanisms. To test for shared genetic underpinnings, we performed multi-trait colocalization across SZ, structural MRI measures (bilateral cortical thickness, grey matter volume), insulin resistance markers (TG:HDL-C ratio, fasting insulin adjusted for BMI), and IL-6 signalling traits (IL-6, IL-6R, IL-6ST) at 185 genome-wide significant loci. Colocalization was detected at 53 loci, including a robust cluster at the SLC39A8 missense variant rs13107325 linking SZ with cortical structure, peripheral IL-6ST, and TG:HDL-C (PP _coloc = 0.73–0.99). A secondary, lower-confidence colocalization signal at FGF21 (PP _coloc = 0.6) further implicated metabolic– behavioural coupling as a convergent pathway. Downstream analyses of rs13107325 pQTLs indicated enrichment in synaptic development and cardiometabolic pathways. Together, these findings identify rs13107325 as a shared causal variant bridging neurodevelopment, immunity, and metabolism, and highlight metal-ion transport and FGF21 signalling as potential therapeutic entry points to address the intertwined psychiatric and metabolic burden of SZ.